---
symbol: "NVDA"
name: "NVIDIA"
date: 2026-09-22
change_pct: 1.943051575931221
direction: "up"
event_type: "m&a"
url: "https://perplo.app/why/NVDA/2026-09-22"
updated_at: 2026-09-22T01:06:37.508Z
---

# Why NVIDIA (NVDA) rose 1.94% on September 22, 2026

NVIDIA (NVDA) rose 1.94% on September 22, 2026 — Iambic IPO expands Nvidia's AI-drug empire.

## What happened

Iambic Therapeutics, a Nvidia-backed and Qatar Investment Authority–backed biotech startup, filed for a US IPO, extending the chain of AI-drug discovery companies built on Nvidia's capital and infrastructure.

## Why it moved

A successful biotech IPO powered by Nvidia's ecosystem reinforces the narrative that Nvidia's compute is unlocking new markets (drug discovery) and attracting institutional capital; it signals sustained appetite for…

## Why it matters

AI Compute supercycle is fueled by expanding TAM across hyperscalers, enterprises, and now life sciences — Iambic's IPO demonstrates that Nvidia is not just selling chips, but seeding entire downstream markets dependent…

## What would break the thesis

If the IPO is pulled or prices weakly, it signals collapsing risk appetite and could spook confidence in the broader AI ecosystem boom; also watch whether biotech IPOs actually drive meaningful GPU utilization or remain…

## Sources

- [Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on](https://www.investing.com/news/economy-news/nvidia-qiabacked-iambic-therapeutics-files-for-us-ipo-as-biotech-boom-rolls-on-4909708) — Investing.com
- [Goldman's 8,000 S&P forecast rests on hyperscaler spending, NVIDIA data shows the stakes](https://investinglive.com/stock-market-update/goldman-s-8-000-s-p-forecast-rests-on-hyperscaler-spending-nvidia-data-shows-the-stakes/) — ForexLive
- [Jensen Huang Just Delivered Incredible News for Nvidia Stock Investors](https://finnhub.io/api/news?id=f09d6cc1cc93998122a20593925df2ec71cae37489c13f6a50ec7771d44e5510) — Yahoo

---

Trade NVDA perpetual futures 24/7 onchain: https://perplo.app/asset/NVDA